Government Pledges National Action Plan for Rare Cancer Treatments
What happened
The Government announced a major breakthrough in brain cancer care, including the appointment of a national brain cancer clinical lead. This decision followed lobbying efforts by Charlie Maynard and the campaign group Brain Cancer Justice. The Government also pledged to develop a national action plan and review rules regarding rare cancer medicines.
From oxfordmail.co.uk
Why it matters
The commitments include reviewing rules on rare cancer medicines and increasing patient participation in clinical trials. This regulatory action by the Government could affect the availability and speed of new treatments for patients.
From oxfordmail.co.uk
Who's involved
- Charlie MaynardMember of Parliament for Witney who lobbied for improved cancer care.
- governmentThe governing body that announced the national action plan and clinical lead.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- governmentSpeculative
The Government might face changes in regulatory oversight and costs related to reviewing rare cancer medicine rules.
Possible ripples
Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.Keep exploring
The entities involved
-
Charlie Maynard
British politician
Nothing else this week.
-
Witney
town and civil parish in West Oxfordshire, England
Nothing else this week.
-
parliament
legislative body of government